Focused on the cultivation
and supply of THC dominant medical cannabis products, from plant to patient.

Located in the heart of Europe, we are in a prime position for European distribution.

The European medical cannabis market is expected to reach €43.3 bn by 2027 up from €4 bn in 2019.

JUMP TO

About us [01]

Founded in 2018, Hellenic Dynamics is a licensed cultivator and supplier of finished pharmaceutical standard medical cannabis products operating from a dedicated 195,506 square meter facility set in the rolling hills of Northern Greece. Hellenic Dynamics is specifically involved in the cultivation, production and export of tetrahydrocannabinol (“THC”) dominant strains of dried medical cannabis flowers and flower extracts to the growing medical cannabis markets across Europe, worth €4.09bn in 2019 and expected to reach €43.3bn by 2027, growing at a CAGR of 29.6% during this period.

overview img

Medical cannabis, especially in higher THC doses, has been approved for use in the United Kingdom and Germany plus 24 other European countries for conditions including but not limited to chronic pain, Spinal cord treatment, Anxiety, HIV/AIDS Appitite loss, Multiple Sclerosis, Crohn’s disease, PTSD, Chemotherapy side effects, Glaucoma, Anorexia, Lennox-Gastaut syndrome, Alzheimer’s, Dravet syndrome, Tourette’s syndrome, Intractable spasticity and Cachexia.

Hellenic was awarded its licence from the Greek government in 2019 for a total of 40,000 square meters of active cultivation area within our facility, with no limitations on the THC content of the cultivars grown, the overall volume of production or total export quantities of flowers per annum. This is one of the largest licences of its kind issued in Europe due to the size and scale of the facility and the high regulatory standards under which Hellenic Dynamics operates.

Hellenic Dynamics has an experienced management team with significant medial cannabis cultivation and business development experience. This skillset is underpinned by a number of high profile partnerships and collaboration agreements that cover all aspects of the Company’s marketing, sales, security and existing legislative and legal frameworks both domestically and for target European sales territories.

Hellenic Dynamics

Highlights of our
business model

[02]

Hellenic Dynamics can produce one of the highest quality dried medical cannabis flowers at one of the lowest costs of production in Europe.

Prime position to capitalize on the European medical cannabis market estimated to be worth €37 bn by 2027.

Team has extensive medical cannabis cultivation experience at scale along with public markets background.

Intention to build a proprietary IP protected library of THC dominant genetics.

Partnership with the American Farm School, Southern Europe’s preeminent agricultural institution.

25 countries in Europe now allow the supply of THC Medical Cannabis via prescription.

Integrated model spans cultivation, production, and distribution.

One of the lowest power, utility and skilled labor costs in Europe with easy distribution to all target markets.

Off take agreements in place for THC dominant products into first target market Germany.

Hellenic Dynamics

We have a range of products
in our cultivation
strategy which responds to
European demand

Strategy spans five phases of development each increasing the total cultivation area based on growing European demand

Europe is set to be the largest medical cannabis market in the world, with 25 countries having passed legislation for patient access.

Disclaimer

The information on this website is being made available by Hellenic Dynamics PLC (“LON:HELD”) in good faith and for information purposes only. Please read this notice carefully - it applies to all persons who view this Website. Please note that this notice may be altered or updated. You should therefore read it in full each time you visit this Website. The information contained on this Website is not comprehensive and much of it is historical. No reliance may be placed for any purpose whatsoever on the suitability of the shares of LON:HELD for any prospective investor and LON:HELD, its directors, shareholders, advisers, affiliates, agents, representatives and employees assume no responsibility to you or any third party for the consequences of any errors or omissions. Neither LON:HELD, its directors, shareholders, advisers, affiliates, agents, representatives nor employees accept any liability for any direct or indirect or consequential loss or damages of any kind resulting from any use of this Website or any information contained on it. Some of the statements contained on this Website and in documents accessed through this Website may be forward looking statements. Actual results may differ from those expressed in such statements, depending on a variety of factors. The past performance of LON:HELD or its shares cannot be relied on as a guide to future performance. The price of the shares may go down as well as up and it may be that investors do not recoup the amount originally invested. This Website and the information on it does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in LON:HELD, nor shall it (or any part of it) or the fact of its distribution form the basis of, or be relied on in connection with or act as an inducement to enter into any contract or commitment therefor and any decisions you make based on the information contained on this Website are your sole responsibility having, where appropriate, taken independent advice as to the investment decision and any laws or regulations applicable to such investment decision. The information contained in this section of the Website is not directed at, nor is it intended for access by, persons located or resident in the United States, Australia, Canada, the Republic of South Africa, or Japan or any other jurisdiction in which it may be unlawful to receive or view such information. If you are not permitted to view the information (or are in any doubt as to whether you are permitted to view the information), please exit this Website. Any shares of LON:HELD referred to in the information on this Website have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended. Such shares have also not been registered under the applicable securities laws of Australia, Canada, the Republic of South Africa or Japan and may not be offered or sold in Australia, Canada, the Republic of South Africa or Japan or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereof in, such jurisdiction. LON:HELD, its directors, shareholders, advisers, affiliates, agents, representatives and employees (whether or not involved in creating, producing, maintaining or delivering this Website) exclude all liability and responsibility for any amount or kind of loss party in connection with this Website in or the information contained on it.

By clicking [Accept] you accept you have read the terms of this Important Notice.